Meyka Pro banner
Milestone Scientific Inc.

Milestone Scientific Inc. Fundamental Analysis (AMEX: MLSS)

MLSS●AMEX
HealthcareMedical - Instruments & Supplies
$0.24
$0.002(0.83%)
U.S. Market opens in 51h 34m

Milestone Scientific Inc. Fundamental Analysis (AMEX: MLSS)

Milestone Scientific Inc. (AMEX: MLSS) shows moderate financial fundamentals with a PE ratio of -5.67, profit margin of -40.27%, and ROE of -1.22%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 3.99%.

Key Strengths

PEG Ratio-0.07
Current Ratio2.06

Areas of Concern

ROE-1.22%
Operating Margin-40.04%
We analyze MLSS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -118.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-118.8/100

We analyze MLSS's fundamental strength across five key dimensions:

Efficiency Score

Weak

MLSS struggles to generate sufficient returns from assets.

ROA > 10%
-53.83%

Valuation Score

Excellent

MLSS trades at attractive valuation levels.

PE < 25
-5.67
PEG Ratio < 2
-0.07

Growth Score

Weak

MLSS faces weak or negative growth trends.

Revenue Growth > 5%
3.99%
EPS Growth > 10%
-18.44%

Financial Health Score

Excellent

MLSS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
2.06

Profitability Score

Weak

MLSS struggles to sustain strong margins.

ROE > 15%
-122.29%
Net Margin ≥ 15%
-40.27%
Positive Free Cash Flow
No

Key Financial Metrics

Is MLSS Expensive or Cheap?

P/E Ratio

MLSS trades at -5.67 times earnings. This suggests potential undervaluation.

-5.67

PEG Ratio

When adjusting for growth, MLSS's PEG of -0.07 indicates potential undervaluation.

-0.07

Price to Book

The market values Milestone Scientific Inc. at 6.08 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.08

EV/EBITDA

Enterprise value stands at -6.38 times EBITDA. This is generally considered low.

-6.38

How Well Does MLSS Make Money?

Net Profit Margin

For every $100 in sales, Milestone Scientific Inc. keeps $-40.27 as profit after all expenses.

-40.27%

Operating Margin

Core operations generate -40.04 in profit for every $100 in revenue, before interest and taxes.

-40.04%

ROE

Management delivers $-1.22 in profit for every $100 of shareholder equity.

-1.22%

ROA

Milestone Scientific Inc. generates $-53.83 in profit for every $100 in assets, demonstrating efficient asset deployment.

-53.83%

Following the Money - Real Cash Generation

Operating Cash Flow

Milestone Scientific Inc. generates limited operating cash flow of $-1.42M, signaling weaker underlying cash strength.

$-1.42M

Free Cash Flow

Milestone Scientific Inc. generates weak or negative free cash flow of $-1.41M, restricting financial flexibility.

$-1.41M

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

MLSS converts -6.74% of its market value into free cash.

-6.74%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.67

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.08

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.31

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.06

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.22

vs 25 benchmark

ROA

Return on assets percentage

-0.54

vs 25 benchmark

ROCE

Return on capital employed

-1.01

vs 25 benchmark

How MLSS Stacks Against Its Sector Peers

MetricMLSS ValueSector AveragePerformance
P/E Ratio-5.6730.24 Better (Cheaper)
ROE-122.29%540.00% Weak
Net Margin-40.27%-2322.00% (disorted) Weak
Debt/Equity0.030.08 Strong (Low Leverage)
Current Ratio2.065.59 Strong Liquidity
ROA-53.83%-17516.00% (disorted) Weak

MLSS outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Milestone Scientific Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

26.83%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

40.07%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

67.91%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ